Drug connectivity mapping and functional analysis reveal therapeutic small molecules that differentially modulate myelination

Disruption or loss of oligodendrocytes (OLs) and myelin has devastating effects on CNS function and integrity, which occur in diverse neurological disorders, including Multiple Sclerosis (MS), Alzheimer’s disease and neuropsychiatric disorders. Hence, there is a need to develop new therapies that pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: A.D. Rivera, F. Pieropan, G. Williams, F. Calzolari, A.M. Butt, K. Azim
Format: article
Langue:EN
Publié: Elsevier 2022
Sujets:
Accès en ligne:https://doaj.org/article/9c39d9c18650411aa069869eba42e464
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!